Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertoletti

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Clinical and Molecular Hepatology|October 11, 2024
Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Antonio Bertoletti, Anthony T Tan
Nature Reviews. Gastroenterology & Hepatology|January 6, 2017
HBV in 2016: Global and immunotherapeutic insights into hepatitis BMala K Maini, Antonio Bertoletti
Seminars in Immunopathology|May 21, 2021
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognitionMaura Dandri, Antonio Bertoletti, Marc Lütgehetmann
Gut|February 1, 2019
HBV antiviral immunity: not all CD8 T cells are born equalAntonio Bertoletti, Patrick T F Kennedy
Cells|August 27, 2021
Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent CancerMorteza Hafezi, Anthony Tan, Antonio Bertoletti
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA ElectroporationSarene Koh, Noriko Shimasaki, Antonio Bertoletti
Cold Spring Harbor Perspectives in Medicine|July 3, 2015
Immune Response in Hepatitis B Virus InfectionAnthony Tan, Sarene Koh, Antonio Bertoletti
Nature Reviews. Immunology|October 4, 2024
Beyond exhaustion: the unique characteristics of CD8<sup>+</sup> T cell dysfunction in chronic HBV infectionRobert Thimme, Antonio Bertoletti, Matteo Iannacone
Antiviral Therapy|November 3, 2010
The host-pathogen interaction during HBV infection: immunological controversiesAntonio Bertoletti, Mala K Maini, Carlo Ferrari
Cytotherapy|August 30, 2017
T-cell therapy for chronic viral hepatitisAntonio Bertoletti, Anthony Tanoto Tan, Sarene Koh
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Clinical and Molecular Hepatology|October 11, 2024
Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Antonio Bertoletti, Anthony T Tan
Nature Reviews. Gastroenterology & Hepatology|January 6, 2017
HBV in 2016: Global and immunotherapeutic insights into hepatitis BMala K Maini, Antonio Bertoletti
Seminars in Immunopathology|May 21, 2021
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognitionMaura Dandri, Antonio Bertoletti, Marc Lütgehetmann
Gut|February 1, 2019
HBV antiviral immunity: not all CD8 T cells are born equalAntonio Bertoletti, Patrick T F Kennedy
Cells|August 27, 2021
Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent CancerMorteza Hafezi, Anthony Tan, Antonio Bertoletti
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA ElectroporationSarene Koh, Noriko Shimasaki, Antonio Bertoletti
Cold Spring Harbor Perspectives in Medicine|July 3, 2015
Immune Response in Hepatitis B Virus InfectionAnthony Tan, Sarene Koh, Antonio Bertoletti
Nature Reviews. Immunology|October 4, 2024
Beyond exhaustion: the unique characteristics of CD8<sup>+</sup> T cell dysfunction in chronic HBV infectionRobert Thimme, Antonio Bertoletti, Matteo Iannacone
Antiviral Therapy|November 3, 2010
The host-pathogen interaction during HBV infection: immunological controversiesAntonio Bertoletti, Mala K Maini, Carlo Ferrari
Cytotherapy|August 30, 2017
T-cell therapy for chronic viral hepatitisAntonio Bertoletti, Anthony Tanoto Tan, Sarene Koh
Pageof 23